JOHANNESBURG - The World Health Organization says a first patient has been enrolled in a clinical trial testing two potential treatments for the Ebola outbreak in the Democratic Republic of the Congo.
The trial is expected to assess whether the new medicines are safe and effective to treat the growing outbreak.
Tedros Adhanom Ghebreyesus, World Health Organization chief, said patients who enrol in the trial will receive comprehensive supportive care and close follow-up.
"Earlier today, the clinical trial of two therapeutics began, with the enrolment of the first patient. The partners in this trial will evaluate the monoclonal antibody MBP134 and the antiviral drug remdesivir alone and in combination.
“The study is being coordinated by DRC's National Institute for Biomedical Research, supported by a coalition of partners including WHO and conducted in close cooperation with the affected communities,” Ghebreyesus said.